FourPoints Investment Managers’s Teva Pharmaceuticals TEVA Stock Holding History

FourPoints Investment Managers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,992	Closed	-$295K	–	83
2015 Q2	$295K	Hold	4,992	–	–	0.07%	72
2015 Q1	$311K	Sell	4,992 -3,630	-42%	-$211K	0.06%	74
2014 Q4	$496K	Hold	8,622	–	–	0.08%	76
2014 Q3	$463K	Hold	8,622	–	–	0.05%	79
2014 Q2	$452K	Sell	8,622 -4,925	-36%	-$252K	0.04%	81
2014 Q1	$716K	Sell	13,547 -10,453	-44%	-$483K	0.07%	76
2013 Q4	$962K	Hold	24,000	–	–	0.09%	79
2013 Q3	$907K	Hold	24,000	–	–	0.08%	80
2013 Q2	$941K	Buy	+24,000	New	+$935K	0.09%	76

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FourPoints Investment Managers's TEVA Position: Q3 2015 in Review

FourPoints Investment Managers sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 4,992 shares — an estimated $295K sold.

FourPoints Investment Managers first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $962K in Q4 2013. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

FourPoints Investment Managers reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
FourPoints Investment Managers sold 4,992 Teva Pharmaceuticals shares in Q3 2015, an estimated $295K.
FourPoints Investment Managers first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 9 quarters.
FourPoints Investment Managers's Teva Pharmaceuticals position peaked at $962K in Q4 2013.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on FourPoints Investment Managers's 13F filing for Q3 2015, filed 13 Nov 2015.